Spots Global Cancer Trial Database for recurrent childhood visual pathway glioma

Every month we try and update this database with for recurrent childhood visual pathway glioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Carboplatin in Patients With Progressive Gliomas	NCT00002749	Brain and Centr...	carboplatin	-	Duke University
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors	NCT00002647	Brain and Centr... Metastatic Canc...	verteporfin conventional su...	3 Years - 70 Years	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Children With Progressive Brain Tumors	NCT00002944	Brain Tumors Central Nervous...	carboplatin lomustine procarbazine hy... thioguanine vincristine sul...	- 9 Years	Children's Oncology Group
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment	NCT00929903	Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Metastatic Chil... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Unspecified Chi...	pazopanib hydro... pharmacological...	2 Years - 25 Years	National Cancer Institute (NCI)
18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas	NCT02175745	Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Adult Pilocytic... Adult Pineal Gl... Adult Subependy... Childhood High-... Childhood High-... Childhood Low-g... Childhood Low-g... Recurrent Adult... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child...	18F-fluoro-dihy... Positron emissi... Computed tomogr... Magnetic resona...	16 Years -	Stanford University
O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors	NCT00003765	Brain and Centr...	O6-benzylguanin... carmustine	- 21 Years	National Cancer Institute (NCI)
Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma	NCT01553149	Neurofibromatos... Recurrent Child... Recurrent Child...	Lenalidomide Pharmacological...	- 21 Years	National Cancer Institute (NCI)
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors	NCT02415153	Neurofibromatos... Recurrent Child... Recurrent Child... Recurrent Prima... Refractory Prim...	Laboratory Biom... Pharmacological... Pomalidomide	3 Years - 20 Years	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Children With Progressive Brain Tumors	NCT00002944	Brain Tumors Central Nervous...	carboplatin lomustine procarbazine hy... thioguanine vincristine sul...	- 9 Years	Children's Oncology Group
Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma	NCT01553149	Neurofibromatos... Recurrent Child... Recurrent Child...	Lenalidomide Pharmacological...	- 21 Years	National Cancer Institute (NCI)
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors	NCT01158300	Brain and Centr...	VEGF inhibitor ...	3 Years - 21 Years	Pediatric Brain Tumor Consortium
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer	NCT01132547	Cancer	cyproheptadine ... placebo	2 Years - 21 Years	University of South Florida
Carboplatin in Patients With Progressive Gliomas	NCT00002749	Brain and Centr...	carboplatin	-	Duke University
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment	NCT00929903	Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Metastatic Chil... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Unspecified Chi...	pazopanib hydro... pharmacological...	2 Years - 25 Years	National Cancer Institute (NCI)
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors	NCT02194452	Acoustic Schwan... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Craniopha... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade I M... Adult Grade II ... Adult Medullobl... Adult Meningeal... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Papillary... Adult Pilocytic... Adult Pineal Gl... Adult Pineoblas... Adult Pineocyto... Adult Subependy... Adult Subependy... Adult Supratent... Childhood Choro... Childhood Crani... Childhood Epend... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Low-g... Childhood Medul... Childhood Supra... Meningeal Melan... Newly Diagnosed... Recurrent Adult... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child...	gallium Ga 68-e... positron emissi... computed tomogr... laboratory biom...	6 Months - 29 Years	University of Iowa

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: